Healthy Extracts (HYEX) Total Non-Current Liabilities (2015 - 2025)

Healthy Extracts' (HYEX) quarterly Total Non-Current Liabilities came in at $2.1 million in Q4 2025, up 235.58% year-on-year from $627847.0 in Q4 2024, and up 120.42% quarter-over-quarter from $955856.0 in Q3 2025.

Healthy Extracts (HYEX) Total Non-Current Liabilities (2015 - 2025) Analysis & Trends

Healthy Extracts' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $2.1 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 235.58% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 235.58% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 235.58% from the prior year.
  • Total Non-Current Liabilities climbed to $2.1 million in Q4 2025 per HYEX's latest filing, from $955856.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.9 million in Q4 2021 and bottomed at -$910779.0 in Q1 2024.
  • The 5-year median for Total Non-Current Liabilities is $1.4 million (2023), against an average of $1.3 million.
  • Across the five-year window, Total Non-Current Liabilities soared 1780.25% in 2021 and sank 1279.58% in 2023, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $2.9 million in 2021, then dropped by 10.56% to $2.6 million in 2022, then retreated by 5.56% to $2.5 million in 2023, then tumbled by 74.69% to $627847.0 in 2024, then surged by 235.58% to $2.1 million in 2025.
  • Per Business Quant, the three latest HYEX Total Non-Current Liabilities figures stand at $2.1 million (Q4 2025), $955856.0 (Q3 2025), and $1.2 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Healthy Extracts 14.70 Mn 14.56 Mn 957,429.00 2.11 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.11 Mn
Sep 30, 2025 955,856.00
Jun 30, 2025 1.16 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 627,847.00
Sep 30, 2024 1.02 Mn
Jun 30, 2024 -736,623.00
Mar 31, 2024 -910,779.00
Dec 31, 2023 2.48 Mn
Sep 30, 2023 1.39 Mn
Jun 30, 2023 1.48 Mn
Mar 31, 2023 -186,919.00
Dec 31, 2022 2.63 Mn
Sep 30, 2022 1.53 Mn
Jun 30, 2022 1.74 Mn
Mar 31, 2022 -13,549.00
Dec 31, 2021 2.94 Mn
Sep 30, 2021 2.14 Mn
Jun 30, 2021 2.62 Mn
Mar 31, 2021 634,057.00